JDR—Antibiotic Therapy for Acne Vulgaris (Part 1)

MARCH 4, 2020

JCAD Editor in Chief James Del Rosso, DO discusses advantages of a recently approved topical minocycline foam for acne vulgaris.

Benzoyl Peroxide’s 60th Anniversary

JCAD Editor in Chief Jim Del Rosso, DO, reports from the 2020 Winter Clinical Dermatology conference to discuss microencapsulation of active ingredients in topical formulations and the host of benefits that accompanies this new technology....

Jim Del Rosso: Development Program for Oral Sarecycline for Acne

In the third part of this three-part series on oral antibiotic therapy for acne, Dr. Del Rosso discusses the development program for sarecycline, the newest tetracycline-class antibiotic for acne....

Benzoyl Peroxide’s 60th Anniversary

Jimmy on the Street

Jim Del Rosso: Development Program for Oral Sarecycline for Acne

In the third part of this three-part series on oral antibiotic therapy for acne, Dr. Del Rosso discusses the development program for sarecycline, the newest tetracycline-class antibiotic for acne....

Jimmy on the Street

Jim Del Rosso: Oral Antibiotic Therapy for Acne

In the first of this three-part series on oral antibiotic therapy for acne, Dr. Jim Del Rosso discusses patient counseling around acne treatment plans that include oral antibiotics and reviews...

Jimmy on the Street

Jim Del Rosso: Antimicrobial Considerations for Acne Therapies

In the second of this three-part series on oral antibiotic therapy for acne, Dr. Jim Del Rosso discusses antimicrobial considerations, with a focus on differentiating features of the newest tetracycline-class...

JDR—Antibiotic Therapy for Acne Vulgaris (Part 1)

MARCH 4, 2020

MORE FROM JCAD TV